JP2023512782A5 - - Google Patents
Info
- Publication number
- JP2023512782A5 JP2023512782A5 JP2022547871A JP2022547871A JP2023512782A5 JP 2023512782 A5 JP2023512782 A5 JP 2023512782A5 JP 2022547871 A JP2022547871 A JP 2022547871A JP 2022547871 A JP2022547871 A JP 2022547871A JP 2023512782 A5 JP2023512782 A5 JP 2023512782A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- antibody
- hepsin
- seq
- consensus sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970626P | 2020-02-05 | 2020-02-05 | |
| US62/970,626 | 2020-02-05 | ||
| PCT/US2021/016409 WO2021158660A2 (en) | 2020-02-05 | 2021-02-03 | Anti-hepsin antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512782A JP2023512782A (ja) | 2023-03-29 |
| JP2023512782A5 true JP2023512782A5 (enExample) | 2024-01-31 |
Family
ID=77200525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547871A Pending JP2023512782A (ja) | 2020-02-05 | 2021-02-03 | 抗ヘプシン抗体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230236192A1 (enExample) |
| EP (1) | EP4100062A4 (enExample) |
| JP (1) | JP2023512782A (enExample) |
| KR (1) | KR20220137696A (enExample) |
| CN (1) | CN115427075A (enExample) |
| AU (1) | AU2021215999A1 (enExample) |
| BR (1) | BR112022015523A2 (enExample) |
| CA (1) | CA3169809A1 (enExample) |
| IL (1) | IL295258A (enExample) |
| MX (1) | MX2022009584A (enExample) |
| WO (1) | WO2021158660A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025259819A1 (en) * | 2024-06-11 | 2025-12-18 | Navaux, Inc. | Anti-hepsin antibodies and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007524605A (ja) * | 2003-04-03 | 2007-08-30 | ピーディーエル バイオファーマ，インコーポレイティド | インテグリンα５β１のインヒビターおよび組織顆粒化の制御のためのそれらの使用 |
| US20050025763A1 (en) * | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
| US7029675B1 (en) * | 2003-06-04 | 2006-04-18 | Shu-Wha Lin | Hepsin antagonist and methods of use |
| US8383351B2 (en) * | 2008-06-11 | 2013-02-26 | Oxford Brookes University | Antibody to inhibin/ activin β-B subunit |
| WO2010082034A1 (en) * | 2009-01-16 | 2010-07-22 | University Of Exeter | Antibody |
| RU2559533C2 (ru) * | 2009-10-22 | 2015-08-10 | Дженентек, Инк. | Антитела против гепсина и способы их применения |
| WO2011161189A1 (en) * | 2010-06-24 | 2011-12-29 | F. Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods of use |
| CN102093479B (zh) * | 2010-11-29 | 2012-10-03 | 侯宗柳 | 抗人血管内皮生长因子受体2的重组嵌合抗体 |
| EP2721417A4 (en) * | 2011-06-17 | 2015-05-06 | Univ Arkansas | NEW MARKERS FOR EARLY DIAGNOSIS OF EGG CANCER, MONITORING DURING THE CORRESPONDING THERAPY AND NEW THERAPY OPTIONS DURING AND AFTER THE CORRESPONDING CHEMOTHERAPY |
| US20180305702A1 (en) * | 2015-09-15 | 2018-10-25 | Advaxis, Inc. | Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment |
-
2021
- 2021-02-03 MX MX2022009584A patent/MX2022009584A/es unknown
- 2021-02-03 WO PCT/US2021/016409 patent/WO2021158660A2/en not_active Ceased
- 2021-02-03 BR BR112022015523A patent/BR112022015523A2/pt unknown
- 2021-02-03 KR KR1020227030350A patent/KR20220137696A/ko active Pending
- 2021-02-03 CA CA3169809A patent/CA3169809A1/en active Pending
- 2021-02-03 AU AU2021215999A patent/AU2021215999A1/en active Pending
- 2021-02-03 EP EP21750332.5A patent/EP4100062A4/en active Pending
- 2021-02-03 JP JP2022547871A patent/JP2023512782A/ja active Pending
- 2021-02-03 IL IL295258A patent/IL295258A/en unknown
- 2021-02-03 CN CN202180026877.6A patent/CN115427075A/zh active Pending
-
2022
- 2022-08-04 US US17/817,539 patent/US20230236192A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2769427C (en) | Anti-cmet antibody and its use for the detection and the diagnosis of cancer | |
| AU2013361617B2 (en) | Antibodies that bind to human programmed Death Ligand 1 (PD-L1) | |
| CN102971343B (zh) | 用于癌症诊断和/或预后的新型抗体 | |
| CN116731182A (zh) | 靶向dll3的抗体、抗原结合片段及其用途 | |
| JP2021517152A5 (enExample) | ||
| KR20220143834A (ko) | 항 d-이량체 재조합 항체, 이의 방법 및 용도 | |
| CN112094348B (zh) | 抗人Tim3抗体或其功能性片段及其应用 | |
| CN117683121B (zh) | 抗水痘-带状疱疹病毒抗体及其应用 | |
| JP6977105B2 (ja) | Ｉｇｆ−１ｒ抗体および癌の診断のためのその使用 | |
| AU2016333540A1 (en) | GDF-15 as a diagnostic marker for melanoma | |
| JP2023512782A5 (enExample) | ||
| CN113880948B (zh) | 抗ca724抗体或其抗原结合片段及其制备方法和应用 | |
| US20250102524A1 (en) | Hemoglobin g-makassar binding polypeptides and antibodies and methods of using the same | |
| CN111471109A (zh) | 一种抗成纤维细胞生长因子受体4单克隆抗体及其制备方法和用途 | |
| KR102314451B1 (ko) | 단백질 키나아제 a의 촉매 서브 유닛 알파에 특이적으로 결합하는 단일클론항체 및 이를 활용한 암 진단 용도 | |
| JP7086607B2 (ja) | Ｉｇｆ－１ｒ抗体および癌の診断のためのその使用 | |
| KR102601835B1 (ko) | 말 인플루엔자 바이러스 h3n8형에 특이적인 단일클론항체 및 이를 이용한 말인플루엔자 바이러스 검출용 조성물 | |
| CN115850495A (zh) | 一种抗pivka ii单克隆抗体及其应用 | |
| CN115561456B (zh) | 体外定量b肝病毒大表面蛋白的套组以及用于处理肝病的生物指标组及单株抗体组 | |
| CN114761042A (zh) | Il-38特异性抗体 | |
| CN120424221B (zh) | 靶向德曲妥珠单抗的抗体及其用途 | |
| CN118440189B (zh) | 抗p24抗体、检测p24的试剂和试剂盒 | |
| TW201915016A (zh) | 單株抗體或其抗原結合片段及其用途 | |
| CN120441707B (zh) | 结合特瑞普利单抗的抗体及其用途 | |
| CN116836291B (zh) | 抗cd47-cldn18.2双特异性抗体的抗独特型抗体及其制备方法和应用 |